Among other best practice advice from the American Gastroenterological Association, precancerous colorectal lesions in patients with inflammatory bowel disease (IBD) should be described as polypoid, nonpolypoid, or invisible using a modified Paris Classification.
Patients in a Swedish study whose nonalcoholic fatty liver disease (NAFLD) was confirmed on biopsy were more likely to experience incident major adverse cardiovascular events (MACE).
Levels of urine liver fatty acid-binding protein could be used together with Model for End-stage Liver Disease scoring to improve predictions of liver failure or death, according to an analysis of patients hospitalized for decompensated cirrhosis.
This month's quiz asks readers to determine the most appropriate diagnostic test to perform next in a 55-year-old patient with iron deficiency anemia after an upper endoscopy and a colonoscopy did not find the source of suspected small-bowel bleeding.
An In the Clinic article provided an overview of caring for patients with abnormal liver test results in primary care settings, including evaluation, management, practice improvement, and patient education.
In adults with obesity, metabolic–bariatric surgery vs. usual care is associated with lower all-cause mortality
A recent meta-analysis leaves little question that metabolic surgery is lifesaving compared with usual care, yet only 1% of eligible patients are treated with surgery, an ACP Journal Club commentary noted.
FDA requires updated boxed warnings on heart-related events, other risks for certain Janus kinase inhibitors
The agency is requiring revisions to the boxed warning for the arthritis and ulcerative colitis medicine tofacitinib, as well as two other Janus kinase inhibitors, to include information about the risks of serious heart-related events, cancer, blood clots, and death.